Interpretation of conventional survival analysis and competing risk analysis: An example of hypertension and prostate cancer

Christel Häggström, Pär Stattin, Tanja Stocks, Hans Garmo, Lars Holmberg, Mieke Van Hemelrijck

Research output: Contribution to journalArticlepeer-review

Abstract

Most clinical studies use conventional methods for survival analysis and calculate the risk of the event of interest, however, it is important to understand that the study population is also at risk of competing events, for example death from other causes. Moreover, the risk of competing events may be dependent on the participants' characteristics. Whether competing risks are taken into account or not, is of major importance when interpreting study results.Here, we use a practical example to elucidate the interpretational differences of absolute risk estimates obtained with both conventional methods for survival analysis and competing risk analysis. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)850–852
JournalBJU International
Volume118
Issue number6
DOIs
Publication statusPublished - 2016 Mar 31

Subject classification (UKÄ)

  • Cancer and Oncology

Fingerprint

Dive into the research topics of 'Interpretation of conventional survival analysis and competing risk analysis: An example of hypertension and prostate cancer'. Together they form a unique fingerprint.

Cite this